ADVERTISEMENT

Excessive daytime sleepiness linked to increase in Alzheimer’s biomarker

Poor sleep quality may be early warning of AD

FROM JAMA NEUROLOGY

The study was funded by grants from the National Institutes of Health and several foundations. Dr. Carvalho reported no disclosures related to the study. Many of his coauthors reported relationships with a variety of pharmaceutical companies developing therapies for Alzheimer’s.

SOURCE: Carvalho D et al., JAMA Neurol. 2018 Mar 12. doi: 10.1001/jamaneurol.2018.0049